Back to Search
HOSSAM GOUDA, MD
Pulmonary Disease Physician
NPI: 1346352697Individual
Specialties, Licenses & Credentials
Critical Care Medicine (Internal Medicine) Physician
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
22351(NE)
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
4996(SD)
Sleep Medicine (Internal Medicine) Physician
Internal Medicine — Sleep Medicine
Code: 207RS0012X
4301102063(MI)
Research & Publications (20)
Molecular modeling of human acidic mammalian chitinase in complex with the natural-product cyclopentapeptide chitinase inhibitor argifin.
PMID 19666229·Bioorg Med Chem·2009
8-other
Computer-aided rational molecular design of argifin-derivatives with increased inhibitory activity against chitinase B from Serratia marcescens.
PMID 19395258·Bioorg Med Chem Lett·2009
8-other
Computational analysis of the binding affinities of the natural-product cyclopentapeptides argifin and argadin to chitinase B from Serratia marcescens.
PMID 18313305·Bioorg Med Chem·2008
8-other
Three-dimensional solution structure of EM703 with potent promoting activity of monocyte-to-macrophage differentiation.
PMID 16480872·Bioorg Med Chem Lett·2006
4-observational
Stereostructure of luminamicin, an anaerobic antibiotic, via molecular dynamics, NMR spectroscopy, and the modified Mosher method.
PMID 16344486·Proc Natl Acad Sci U S A·2005
8-other
Free energy calculations for theophylline binding to an RNA aptamer: Comparison of MM-PBSA and thermodynamic integration methods.
PMID 12579577·Biopolymers·2003
8-other
Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE.
PMID 19115340·Angew Chem Int Ed Engl·2009
8-other
Design and synthesis of novel delta opioid receptor agonists and their pharmacologies.
PMID 19362480·Bioorg Med Chem Lett·2009
8-other
Solid-phase total synthesis of the chitinase inhibitor Argadin using a supported acetal resin.
PMID 19575041·J Antibiot (Tokyo)·2009
8-other
Structure-based CoMFA as a predictive model - CYP2C9 inhibitors as a test case.
PMID 19391630·J Chem Inf Model·2009
8-other
Lys17 in the 'lasso' peptide lariatin A is responsible for anti-mycobacterial activity.
PMID 19362475·Bioorg Med Chem Lett·2009
8-other
Argifin; efficient solid phase total synthesis and evaluation of analogues of acyclic peptide.
PMID 19297173·Bioorg Med Chem·2009
8-other
What will happen if we do nothing to control trachoma: health expectancies for blinding trachoma in southern Sudan.
PMID 19290039·PLoS Negl Trop Dis·2009
8-other
Mediastinal emphysema due to an isolated facial trauma: a case report.
PMID 18533581·Med Sci Law·2008
5-case
In silico multi-filter screening approaches for developing novel beta-secretase inhibitors.
PMID 18434150·Bioorg Med Chem Lett·2008
8-other
Conformational behavior of oxygenated mycobacterial mycolic acids from Mycobacterium bovis BCG.
PMID 17524352·Biochim Biophys Acta·2007
8-other
Malaria in Egypt, Saudi Arabia and Yemen: a clinical pilot study.
PMID 18383796·J Egypt Soc Parasitol·2007
7-preclinical
Evaluation of MIB-1 and p53 overexpression as risk factors in large cell non-Hodgkin lymphoma in adults.
PMID 19672286·J Egypt Natl Canc Inst·2007
8-other
Lariatins, antimycobacterial peptides produced by Rhodococcus sp. K01-B0171, have a lasso structure.
PMID 16756302·J Am Chem Soc·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 WEISS ST
SAGINAW, MI 48602 - Phone
- (989) 497-2500
Quick Facts
- NPI
- 1346352697
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile